ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGY Allergy Therapeutics Plc

2.90
0.00 (0.00%)
Last Updated: 08:35:16
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.90 2.80 3.00 2.95 2.90 2.90 754,343 08:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.22 138.23M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 2.90p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £138.23 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.22.

Allergy Therapeutics Share Discussion Threads

Showing 2676 to 2698 of 5000 messages
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
25/4/2014
13:02
Our two top guys now have real 'compelling' reasons to be first to market !!!!
jimmyloser
25/4/2014
07:46
Would be nicer to see them buying more shares!
audigger
25/4/2014
07:17
Nice to see the top men being incentivised. impo

25 April 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Grant of Options

Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP') on 24 April 2014 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:

Director Number of provisional Date of distribution Total provisional
shares awarded shares held under
LTIPs
Manuel Llobet 845,000 24 April 2014 3,190,000
---------------------- --------------------- -------------------
Ian Postlethwaite 422,500 24 April 2014 1,595,000
---------------------- --------------------- -------------------


The issuance and distribution of ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of three years. The new Long Term Incentive Plan was adopted by the Board on 20 March 2013.

jimmyloser
17/4/2014
07:06
("Allergy Therapeutics" or "the Company")

Extension of Convertible Loan Note with CFR International SpA

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company, announces that CFR International SpA and the Company have agreed to extend the term of the GBP4.04 million convertible loan made available to the Company on 30 March 2012. The date of maturity of the convertible loan has been extended from 20 April 2014 to 30 September 2014. All other terms for the Convertible Loan remain unchanged









Fascinating news and not unexpected.

Have they moved it back to September so that it can be included in the finals and they now expect the share price to be double so will only have have to issue half the amount of shares?

I hope so.

dyor/impo

jimmyloser
14/4/2014
22:29
will help it attract a US partner for its PQ platform

That is why the surge in interest.....no mention of doing it themselves...attract a partner!!!!!! IMPO/DYOR

Great report and paid for by AGY

jimmyloser
14/4/2014
17:15
Nice bit of Blue, was down when I went out after lunch!.:0))
cube boss
14/4/2014
12:42
All very positive. Thanks Jimmy.
strowan lea
14/4/2014
11:30
Unable to post report, suffice to say very upbeat - excerpt below.

Investor interest in the allergy immunotherapy (AIT) market remains strong following the FDA's approval of the first AIT tablet product and Circassia's recent high-profile £200m IPO. Allergy Therapeutics, which recently gained Health Canada's blessing for its trial plans for Pollinex Quattro (PQ) Grass, hopes the US approval of its competitors' AIT products will help it attract a US partner for its PQ platform. Such a deal would materially transform Allergy's prospects and substantially increase our valuation.

I believe that the company are a client of Edison. The reports are very unbiased and neutral.

impo/dyor

You can subscribe free for Edison reports

jimmyloser
14/4/2014
11:21
Holding here. Can you post it please Jimmy?!?
strowan lea
14/4/2014
11:07
New Edison note out
jimmyloser
11/4/2014
11:33
I am happy to see this settle at circa 20p and to have the belief that the next piece of news could see AGY go stratospheric - lol

impo/dyor

jimmyloser
11/4/2014
11:24
Quietly consolidating at 20p.....
audigger
08/4/2014
11:11
stirring....
barefoot141
08/4/2014
10:53
Interesting line of thinking....no US partner maybe needed!
audigger
08/4/2014
09:42
Nice bit of Blue!.
I think they will carry on as they are and increase turnover in territories they already have sales in, the US will come before the trials in Canada and the US have finished, IMO.:0)
I think they could create their own sales force, they have around 107 sales people now. :0)

cube boss
08/4/2014
07:12
Cube et al, we need some debate lol, so here goes.....

I find this line from the interims statement to be intriguing - what is your take on it. It is the word 'options' that has me intrigued.

"We continue to explore our strategic options for the development and commercialisation of Pollinex Quattro in this territory."

Just what do you see their strategic options being?

Sell the company?
Part of the company?
Create our own sales force al la Circassia?
Appoint an International Medical Company?
Appoint several distributors in various states?

jimmyloser
04/4/2014
17:47
Not that far away - it's champagne these days

lol

Good Luck Cube.
We appear to be on a winner here. Imagine what even a snicket of positive news will do here and you will not be able to imagine what solid news on the USA would do to the share price in your wildest dreams.

impo

jimmyloser
04/4/2014
16:32
Cube
Call by, we're having a party !

This took some shifting today.

Bodes well.

jimmyloser
04/4/2014
16:27
Held up well! Have a nice weekend all.
Going for a weekend of Backgammon in Manchester this weekend..:0)

cube boss
04/4/2014
09:00
Cant resist.

dyor

jimmyloser
03/4/2014
10:16
cube, i bet you are able to sell easily right now. Somebody wants these shares as cheap as they can get them

Looks like holders have rumbled the wicked plan lol

jimmyloser
03/4/2014
08:18
You know my views Jimmy, Totally Agree..:0)
Fill Ya boots..:0)

cube boss
03/4/2014
07:16
Thanks guys for the information. It appears that flaky, panicky sellers along with those who are satisfied with their profits are having every loose share snapped up by real value investors.

This AGY has made a new higher altitude camp having climbed rapidly from the 8p base camp and any further positive news will see it climb higher. When it does announce the USA tie up/strategy, it will sprout wings and fly sky high and I am sure that no one will disagree with that view.

They need twelve months. I am in no hurry.

INVESTORS SHARE.

impo/dyor

jimmyloser
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock